Related Experiment Videos
Chlamydia pneumoniae infection in human monocytes.
S Airenne1, H M Surcel, H Alakärppä
1National Public Health Institute, Oulu, Helsinki, Finland.
Infection and Immunity
|February 20, 1999
Summary
Chlamydia pneumoniae infection in monocytes hinders infectious particle development but remains metabolically active. This persistence may contribute to inflammation and cardiovascular disease progression.
Area of Science:
- Microbiology
- Immunology
- Cardiovascular Research
Background:
- Chlamydia pneumoniae infection is linked to cardiovascular diseases, with monocytes playing a key role in atherosclerosis.
- The persistence of Chlamydia pneumoniae within mononuclear cells remains poorly understood.
Purpose of the Study:
- To investigate the morphology and biological characteristics of Chlamydia pneumoniae infection in human peripheral blood monocytes.
- To understand the factors contributing to the inhibition of infectious progeny development in monocytes.
Main Methods:
- Infection of human peripheral blood monocytes with Chlamydia pneumoniae.
- Confocal and transmission electron microscopy to analyze chlamydial morphology.
- Assessment of chlamydial mRNA expression and lymphocyte proliferative response in infected monocytes.
Main Results:
- Monocytes inhibited the development of infectious Chlamydia pneumoniae progeny, with abnormal inclusion and particle morphology observed.
- Tryptophan or anti-gamma interferon antibodies did not overcome this inhibition, suggesting other chlamydiostatic factors.
- Chlamydial mRNA expression persisted for at least 3 days, and infected monocytes induced lymphocyte proliferation for up to 7 days, indicating metabolic activity.
Conclusions:
- Chlamydia pneumoniae persists metabolically within monocytes despite inhibited progeny development.
- Infected monocytes may contribute to local immune responses and inflammation, potentially exacerbating atherosclerosis.
- Further research is needed to elucidate the mechanisms of chlamydial persistence and its role in cardiovascular pathology.